MedTrace Logo

Diuretics for Postpartum High Blood Pressure in Preeclampsia

NCT02163655 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-10-02

No results posted yet for this study

Summary

The purpose of this study is to determine if furosemide administered after the first 24 hours of delivery, in women with severe peeclampsia and eclampsia accelerates high blood pressure control and diminishes hospital stay.

Conditions

Interventions

DRUG

FUROSEMIDE

Furosemide, 20mg pills, will be administered every 24 houras, for a maximum of five days

DRUG

Placebo

Placebo pills, identical to the intervention (furosemide pills), will be administered every 24 hour for a maximum of five days

Sponsors & Collaborators

  • Instituto Materno Infantil Prof. Fernando Figueira

    lead OTHER

Principal Investigators

  • Leila Katz, MD PhD · IMIP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-20
Primary Completion
2014-11-30
Completion
2015-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02163655 on ClinicalTrials.gov